9 research outputs found
In Situ Coupling of Strung Co<sub>4</sub>N and Intertwined N–C Fibers toward Free-Standing Bifunctional Cathode for Robust, Efficient, and Flexible Zn–Air Batteries
Flexible
power sources with high energy density are crucial for
the realization of next-generation flexible electronics. Theoretically,
rechargeable flexible zinc–air (Zn–air) batteries could
provide high specific energy, while their large-scale applications
are still greatly hindered by high cost and resources scarcity of
noble-metal-based oxygen evolution reaction (OER)/oxygen reduction
reaction (ORR) electrocatalysts as well as inferior mechanical properties
of the air cathode. Combining metallic Co<sub>4</sub>N with superior
OER activity and Co–N–C with perfect ORR activity on
a free-standing and flexible electrode could be a good step for flexible
Zn–air batteries, while lots of difficulties need to be overcome.
Herein, as a proof-of-concept experiment, we first propose a strategy
for in situ coupling of strung Co<sub>4</sub>N and intertwined N–C
fibers, by pyrolyzation of the novel pearl-like ZIF-67/polypyrrole
nanofibers network rooted on carbon cloth. Originating from the synergistic
effect of Co<sub>4</sub>N and Co–N–C and the stable
3D interconnected conductive network structure, the obtained free-standing
and highly flexible bifunctional oxygen electrode exhibits excellent
electrocatalytic activity and stability for both OER and ORR in terms
of low overpotential (310 mV at 10 mA cm<sup>–2</sup>) for
OER, a positive half-wave potential (0.8 V) for ORR, and a stable
current density retention for at least 20 h, and especially, the obtained
Zn–air batteries exhibit a low discharge–charge voltage
gap (1.09 V at 50 mA cm<sup>–2</sup>) and long cycle life (up
to 408 cycles). Furthermore, the perfect bendable and twistable and
rechargeable properties of the flexible Zn–air battery particularly
make it a potentially power portable and wearable electronic device
Supported Cu/Ni Bimetallic Cluster Electrocatalysts Boost CO<sub>2</sub> Reduction
Supported metal clusters
with the integrated advantages
of single-atom
catalysts and conventional nanoparticles held great promise in the
electrocatalytic carbon dioxide reduction (ECO2R) operated
at low overpotential and high current density. However, its precise
synthesis and the understanding of synergistically catalytic effects
remain challenging. Herein, we report a facile method to synthesize
the bimetallic Cu and Ni clusters anchored on porous carbon (Cu/Ni–NC)
and achieve an enhanced ECO2R. The aberration-corrected
high-angle annular dark-field scanning transmission electron microscopy
and synchrotron X-ray absorption spectroscopy were employed to verify
the metal dispersion and the coordination of Cu/Ni clusters on NC.
As a result of this route, the target Cu/Ni–NC exhibits excellent
electrocatalytic performance including a stable 30 h electrolysis
at 200 mA cm–2 with carbon monoxide Faradaic efficiency
of ∼95.1% using a membrane electrode assembly electrolysis
cell. Combined with the in situ analysis of the surface-enhanced Fourier
transform infrared spectroelectrochemistry, we propose that the synergistic
effects between Ni and Cu can effectively promote the H2O dissociation, thereby accelerate the hydrogenation of CO2 to *COOH and the overall reaction process
NO donor dose dependently decreases cell number induced by PDGF-BB and blocks survivin expression and <i>in vitro</i>.
<p>(A), Rat SMC were treated or not with PDGF (10 ng/ml), in the absence or presence of the NO donor, DETA/NO (10, 30, and 100 µM) and cell number quantified after 48 h. (B), NO reduces PDGF induced survivin levels. VSM were treated with PDGF (10 ng/ml) with or withoutt DETA/NONO (10, 30 and 100 µM) and the levels of survivin assessed by Western blotting. DETA/NO dose dependently decreased survivin levels relative to Hsp90 (a protein loading control). Densitometric values of the ratio of survivin to Hsp90 are shown below the blots. * P<0.05, ** P<0.01 with one way ANOVA with Bonferroni posttest.</p
Ad-T34A survivin transduction blocks cell proliferation and restores normal remodeling in eNOS (−/−) mice.
<p>(A) LCs were transduced with Ad-GFP or Ad-T34A survivin at the time of LEC ligation. Lumen diameter and wall thickness were calculated from 10 sections of contralateral RC and infected LC of eNOS (−/−) mice. Upper panel shows lumen diameter of Ad-T34A transduced LC was significantly decreased compared to RC. Ad-T34A transduction also blocks the wall thickening in transduced LC (lower panel). (B), Ad T34A suvivin reduces the number of BrdU positive cells in LC. (C), BrdU labeling index shows significant increase of BrdU positive cell/total nuclei ratio in Ad-GFP transduced LC compare to RC in eNOS (−/−) mice. This activation of cell proliferation was blocked by Ad-T34A transduction. Values are mean ± SEM; * P<0.05, ** P<0.01, and †P<0.001 with one way ANOVA with Bonferroni posttest; n = 5 for each group of mice. Scale bar equals to 25 µm.</p
Molecular Mechanism Behind the Resistance of the G1202R-Mutated Anaplastic Lymphoma Kinase to the Approved Drug Ceritinib
Anaplastic
lymphoma kinase (ALK) has been regarded as an essential
target for the treatment of nonsmall cell lung cancer (NSCLC). However,
the emergence of the G1202R solvent front mutation that confers resistance
to the drugs was reported for the first as well as the second generation
ALK inhibitors. It was thought that the G1202R solvent front mutation
might hinder the drug binding. In this study, a different fact could
be clarified by multiple molecular modeling methodologies through
a structural analogue of ceritinib (compound 10, Cpd-10) that is reported
to be a potent inhibitor against the G1202R mutation. Herein, molecular
docking, accelerated molecular dynamics (aMD) simulations in conjunction
with principal component analysis (PCA), and free energy map calculations
were used to produce reasonable and representative initial conformations
for the conventional MD simulations. Compared with Cpd-10, the binding
specificity of ceritinib between ALK wild-type (ALK<sup>WT</sup>)
and ALK G1202R (ALK<sup>G1202R</sup>) are primarily controlled by
the conformational change of the P-loop- and A-loop-induced energetic
redistributions, and the variation is nonpolar interactions, as indicated
by conventional MD simulations, PCA, dynamic cross-correlation map
(DCCM) analysis, and free energy calculations. Furthermore, the umbrella
sampling (US) simulations were carried out to make clear the principle
of the dissociation processes of ceritinib and Cpd-10 toward ALK<sup>WT</sup> and ALK<sup>G1202R</sup>. The calculation results suggest
that Cpd-10 has similar dissociation processes from both ALK<sup>WT</sup> and ALK<sup>G1202R</sup>, but ceritinib is more easily dissociated
from ALK<sup>G1202R</sup> than from ALK<sup>WT</sup>, thus less residence
time is responsible for the ceritinib resistance. Our results suggest
that both the binding specificity and the drug residence time should
be emphasized in rational drug design to overcome the G1202R solvent
front mutation of ALK resistance
SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice.
<p>(A), Lumen diameters (upper panel) of LC in SU9518 treated eNOS (−/−) mice were reduced in response to a remodeling stimulus but not in LC of vehicle treated eNOS (−/−) mice. Wall thickness (lower panel) of vehicle treated LC was significantly increased and, SU9518 restored the normal wall remodeling in LC. Values are mean ± SEM; n = 7 for each group of mice; * P<0.05, ** P<0.001 with one way ANOVA with Bonferroni posttest. (B) Representative hematoxylin and eosin stained LC cross sections of vehicle or SU9518 treated mice. Inward remodeling can be seen in SU9518 treated LC. Scale bar represents 100 µm. (C), Immunostaining shows BrdU positive cells were detected in all layers of ligated LC in vehicle treated mice (left panel), which blocked by SU9518 treatment as shown on the right panel. Scale bar represents 25 µm. (D), Quantitative BrdU index shows cell proliferation was significantly increased in vehicle treated LCs of eNOS (−/−) mice, but not in vessels from SU9518 treated eNOS (−/−) mice. (E) PDGF-BB receptor tyrosine kinase inhibitor decreases immunoreactive survivin levels in LC of eNOS (−/−) mice, compared to vehicle treated eNOS (−/−) mice (left panel). Right panel shows the quantification of percentage of suvivin positive staining in total vessel area. Values are mean ± SEM; n = 5. * P<0.05, ** P<0.001 with one way ANOVA with Bonferroni posttest.</p
Impaired vascular remodeling in congenic eNOS knockout mice.
<p>(A) Morphometric analysis showing reductions in lumen diameter of LC in C57BL/6J mice with no change in wall thickness in response to a remodeling stimulus, yet no change in lumen diameter but an increase in wall thickness in LC of eNOS (−/−) mice. (B) Hematoxylin and eosin staining showing RC and remodeled LC from a C57BL/6J mouse (upper panel) and RC and remodeled LC from an eNOS (−/−) mouse (lower panel). Scale bar represents 25 µm. Values are mean ± SEM; * P<0.05, ** P<0.01 with one way ANOVA with Bonferroni posttest; n = 5 for each group of mice.</p
Cation Segregation of A‑Site Deficiency Perovskite La<sub>0.85</sub>FeO<sub>3−δ</sub> Nanoparticles toward High-Performance Cathode Catalysts for Rechargeable Li‑O<sub>2</sub> Battery
Cation segregation
of perovskite oxide is crucial to develop high-performance catalysts.
Herein, we achieved the exsolution of α-Fe<sub>2</sub>O<sub>3</sub> from parent La<sub>0.85</sub>FeO<sub>3−δ</sub> by a simple heat treatment. Compared to α-Fe<sub>2</sub>O<sub>3</sub> and La<sub>0.85</sub>FeO<sub>3−δ</sub>, α-Fe<sub>2</sub>O<sub>3</sub>-LaFeO<sub>3–<i>x</i></sub> achieved
a significant improvement of lithium-oxygen battery performance in
terms of discharge specific capacity and cycling stability. The promotion
can be attributed to the interaction between α-Fe<sub>2</sub>O<sub>3</sub> and LaFeO<sub>3–<i>x</i></sub>. During
the cycling test, α-Fe<sub>2</sub>O<sub>3</sub>-LaFeO<sub>3–<i>x</i></sub> can be stably cycled for 108 cycles at a limited
discharge capacity of 500 mAh g<sup>–1</sup> at a current density
of 100 mA g<sup>–1</sup>, which is remarkably longer than those
of La<sub>0.85</sub>FeO<sub>3−δ</sub> (51 cycles), α-Fe<sub>2</sub>O<sub>3</sub> (21 cycles), and mechanical mixing of LaFeO<sub>3</sub> and α-Fe<sub>2</sub>O<sub>3</sub> (26 cycles). In general,
these results suggest a promising method to develop efficient lithium-oxygen
battery catalysts via segregation